Report
EUR 14.01 For Business Accounts Only

MAGELLAN HEALTH sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of MAGELLAN HEALTH (US), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date December 17, 2021, the closing price was USD 94.45 and its potential was estimated at USD 100.74.
Underlying
Magellan Health Inc.

Magellan Health provides managed care services for some of the areas of healthcare. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. The company operates the following segments: Healthcare, which consists of the following reporting units, Behavioral and Specialty Health, and Magellan Complete Care; and Pharmacy Management, which is comprised of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch